BamSEC and AlphaSense Join Forces
Learn More

OneMedNet Corp

NASDAQ: ONMD    
Share price (11/22/24): $0.88    
Market cap (11/22/24): $24.3 million

Material Contracts Filter

EX-10.3
from 8-K 2 pages Amendment to Voting Agreement
12/34/56
EX-10.2
from 8-K 2 pages Amendment to Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages Consulting Agreement
12/34/56
EX-10.3
from 8-K 3 pages Re: OneMedNet Corporation
12/34/56
EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 2 pages Termination Agreement
12/34/56
EX-10.3
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 20 pages OneMedNet Corporation Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 46 pages Standby Equity Purchase Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amendment to the Securities Purchase Agreement
12/34/56
EX-10.13
from S-1/A 7 pages Subscription Escrow Agreement
12/34/56
EX-10.12
from S-1/A 21 pages Registration Rights Agreement
12/34/56
EX-10.11
from S-1/A 35 pages Securities Purchase Agreement
12/34/56
EX-10.10
from S-1/A 11 pages 1. Position. Your Title Will Be CEO and You Will Report to the Board of Directors. This Is a Full-Time, Exempt Position. While You Render Services to the Company, You Will Not Engage in Any Other Employment, Consulting or Other Business Activity (Whether Full-Time or Part- Time) That Would Create a Conflict of Interest With the Company. by Signing This Letter Agreement, You Confirm to the Company That You Have No Contractual Commitments or Other Legal Obligations That Would Prohibit You From Performing Your Duties for the Company
12/34/56
EX-10.9
from S-1/A 9 pages 1. Position. Your Title Will Be Chief Financial Officer, Reporting to the CEO. This Is a Full-Time, Exempt Position. While You Render Services to the Company, You Will Not Engage in Any Other Employment, Consulting or Other Business Activity (Whether Full-Time or Part-Time) That Would Create a Conflict of Interest With the Company. by Signing This Letter Agreement, You Confirm to the Company That You Have No Contractual Commitments or Other Legal Obligations That Would Prohibit You From Performing Your Duties for the Company
12/34/56
EX-10.8
from S-1/A 11 pages 1. Position. Your Title Will Be President and Will Have Dual Reporting to the CEO and the Chairman of the Board. This Is a Full-Time, Exempt Position. While You Render Services to the Company, You Will Not Engage in Any Other Employment, Consulting or Other Business Activity (Whether Full-Time or Part-Time) That Would Create a Conflict of Interest With the Company. by Signing This Letter Agreement, You Confirm to the Company That You Have No Contractual Commitments or Other Legal Obligations That Would Prohibit You From Performing Your Duties for the Company
12/34/56
EX-10.7
from S-1/A 11 pages Subscription Escrow Agreement
12/34/56
EX-10.5
from S-1/A 9 pages This Letter (This “Letter Agreement”) Is Being Delivered to You in Accordance With the Underwriting Agreement (The “Underwriting Agreement”) to Be Entered Into by and Between Data Knights Acquisition Corp., a Delaware Corporation (The “Company”) and Kingswood Capital Markets, Division of Benchmark Investments, Inc., as Representative of the Underwriters (Each, an “Underwriter” and Collectively, the “Underwriters”), Relating to an Underwritten Initial Public Offering (The “Public Offering”), of Up to 11,500,000 of the Company’s Units (Including Up to 1,500,000 Units That May Be Purchased to Cover Over-Allotments, if Any) (The “Units”), Each Comprised of One Share of the Company’s Class a Common Stock, Par Value $0.0001 Per Share (The “Common Stock”), and One Redeemable Warrant. Each Redeemable Warrant (Each, a “Warrant”) Entitles the Holder Thereof to Purchase One Share of Common Stock at a Price of $11.50 Per Share, Subject to Adjustment. the Units Shall Be Sold in the Public Offering Pursuant to a Registration Statement on Form S-1 and Prospectus (The “Prospectus”) Filed by the Company With the Securities and Exchange Commission (The “Commission”) and the Units Have Been Approved to Be Listed on the NASDAQ Capital Market. Certain Capitalized Terms Used Herein Are Defined in Paragraph 11 Hereof
12/34/56